Clinical trial
A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3…
NCT00381082 · Uniquest Pty Ltd, Other · Completed
Key facts
| NCT number | NCT00381082 |
|---|---|
| Title | A Randomised, Assessor-Blind, Comparative Efficacy Clinical Trial of 3 Pediculicides. |
| Official title | A Randomised, Controlled and Blinded Assessment Study of the Efficacy of MOOV Head Lice Treatment (Ego Pharmaceutical Pty. Ltd.) in the Treatment of Head Lice in Primary School Children. |
| Lead sponsor | Uniquest Pty Ltd, Other |
| Collaborators | Ego Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Pediculosis |
| Intervention type | Drug |
| Interventions | 1) MOOV Head Lice Treatment (Ego Pharmaceutical)., Banlice Mousse Aerosol (Pfizer, Australia), 3) KP24 Medicated Foam (Nelson Laboratories) |
| Enrollment | 152 |
| Start date | Sep 1, 2004 |
| Completion | Nov 1, 2004 |
| First posted | Sep 27, 2006 |
| Last update posted | Dec 12, 2006 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: